377 related articles for article (PubMed ID: 24299871)
1. Preparation, characterization, and thermal stability of β-cyclodextrin/soybean lecithin inclusion complex.
Wang X; Luo Z; Xiao Z
Carbohydr Polym; 2014 Jan; 101():1027-32. PubMed ID: 24299871
[TBL] [Abstract][Full Text] [Related]
2. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
3. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J
J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and stuctural behavior of the inclusion complex of beta-cyclodextrin and coptisine hydrochloride].
Chen HY; Jin Z; Chen SQ
Zhong Yao Cai; 2012 Jan; 35(1):138-41. PubMed ID: 22734425
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
6. Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: preparation, characterization, inclusion mode, solubilization and stability.
Ma SX; Chen W; Yang XD; Zhang N; Wang SJ; Liu L; Yang LJ
J Pharm Biomed Anal; 2012; 67-68():193-200. PubMed ID: 22633603
[TBL] [Abstract][Full Text] [Related]
7. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
8. Formation of host-guest complexes of β-cyclodextrin and perfluorooctanoic acid.
Karoyo AH; Borisov AS; Wilson LD; Hazendonk P
J Phys Chem B; 2011 Aug; 115(31):9511-27. PubMed ID: 21688796
[TBL] [Abstract][Full Text] [Related]
9. Preparation, stabilization, and bioefficacy of beta-cyclodextrin inclusion compounds of chloramidophos.
Zhou S; Wang L; Zhang A; Lin K; Liu W
J Agric Food Chem; 2008 Apr; 56(8):2708-13. PubMed ID: 18370398
[TBL] [Abstract][Full Text] [Related]
10. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
Hu L; Zhang H; Song W; Gu D; Hu Q
Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterisation of the supramolecular structure of luteolin/cyclodextrin inclusion complex.
Liu B; Li W; Zhao J; Liu Y; Zhu X; Liang G
Food Chem; 2013 Nov; 141(2):900-6. PubMed ID: 23790865
[TBL] [Abstract][Full Text] [Related]
13. [The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex].
Zhang YM; Li X; Sun CS; Chen CF
Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Mar; 28(3):711-4. PubMed ID: 18536450
[TBL] [Abstract][Full Text] [Related]
14. Preparation of the β-cyclodextrin-vitamin C (β-CD-Vc) inclusion complex under high hydrostatic pressure (HHP).
Hu X; Wei B; Li H; Wu C; Bai Y; Xu X; Jin Z; Tian Y
Carbohydr Polym; 2012 Oct; 90(2):1193-6. PubMed ID: 22840058
[TBL] [Abstract][Full Text] [Related]
15. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
16. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
17. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
18. [Preparation, identification and thermodynamic stability of capsaicin-hydroxypropyl-beta-cyclodextrin inclusion compound].
Chen X; Zhang Z; Ren K; Gong T
Zhongguo Zhong Yao Za Zhi; 2009 Feb; 34(4):394-7. PubMed ID: 19459297
[TBL] [Abstract][Full Text] [Related]
19. Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin.
Shanmuga Priya A; Sivakamavalli J; Vaseeharan B; Stalin T
Int J Biol Macromol; 2013 Nov; 62():472-80. PubMed ID: 24076034
[TBL] [Abstract][Full Text] [Related]
20. Preparation and study on the inclusion complexes of two tanshinone compounds with beta-cyclodextrin.
Yuexian F; Junfen L; Chuan D
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):135-40. PubMed ID: 15556431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
